Celiac Disease Market Opportunities by Key Players, Regional Segmentation and Forecasts, 2018 – 2023
Global Celiac Disease Industry
New Study on “2018-2023 Celiac Disease Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” added to Wise Guy Reports Database
Celiac disease market is an autoimmune disorder caused by the exposure to dietary gluten and damage inner lining of the small intestine. The disease can contribute to several diseases and disorders such as neurological disorder, infertility, low bone density, and certain cancers. There are presently no drugs available for the treatment of celiac disease. It can only be treated by consuming gluten-free diet. The expected launch of Alba/Teva’s larazotide acetate in the US in 2018 and in 5EU in 2019, and the launch of Alvine/AbbVie’s latiglutenase in the US in 2019 and in 5EU in 2020 are considered to fuel the market growth in the celiac disease market. These drugs are anticipated to target patients who undergo gluten exposure.
One of the major factors that is contributing in the market growth is organization of various awareness programs and initiatives taken by the government in different countries for the treatment of celiac disease. The government with such initiatives could strongly boost the market growth. In addition, various funds are offered to research and development activities that is further accelerating the market growth. For example, in Italy, children and adults are tested for celiac disease when they have specific symptoms. Vouchers are given to the diagnosed celiacs for buying specifically produced gluten free foods, up to $168 per month. Moreover, the Italian Celiac Association and government educates restaurants on how to deal with celiac disease. There are even gluten-free meals provided in hospitals, schools, and all other public eating establishments.
The global celiac disease market is analysed on the basis of geographical regions that are contributing significantly to the growth of the market. North America is estimated to be the dominating region in the global celiac disease market. Increasing patient pool in the region owing to increase in consumption of gluten-containing food is one of the major factors that is accelerating the growth of the market in North America.
The companies present actively in the global celiac disease market are Abbott Laboratories, Eli Lilly & Co, Novartis AG, Johnson & Johnson, Alvine Pharmaceuticals Inc., and so on.
The market study of celiac disease market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The OMR team collects facts and data related to the market from different geographies to provide a better regional outlook. In the report, country level analysis is provided by analysing various regional players, regional tax laws and policies, consumer behaviour and macro-economic factors. The numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analysts to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts to get first-hand information. Primary research brings authenticity to our reports.
Secondary sources include:
• Financial reports of companies involved in the market
• Whitepapers, research-papers and news blogs
• Company websites and their product catalogue
• Supplier Websites such as Alibaba, amazon for pricing analysis
The report is intended for hospitals, diagnostics laboratories and research institutes for overall market analysis and competitive analysis. The report provides in-depth analysis on pricing, market size, and intended quality of the product preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models delivering insights into the market for better business decisions.
1. Global celiac disease market by diagnostic type
2. Global celiac disease market by end users
THE REPORT COVERS:
• Comprehensive research methodology of Global Celiac Disease Market.
• This report also includes detailed and extensive market overview with Analyst insights & key market trends.
• Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the Global Celiac Disease Market.
• Insights about market determinants which are stimulating the Global Celiac Disease Market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.
Some points from table of content:
CHAPTER 1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
CHAPTER 2. MARKET OVERVIEW AND INSIGHTS
2.2. ANALYST INSIGHT & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
184.108.40.206. UNITED STATES
220.127.116.11. EUROPEAN UNION
For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3186855-global-celiac-disease-market-research-and-forecast-2018-2023
CHAPTER 3. MARKET DETERMINANTS
3.1.1. PREVALENCE OF CELIAC DISEASES
3.1.2. GOVERNMENT INITIATIVES AND AWARENESS PROGRAMS SUCH AS CELIAC DISEASE AWARENESS CAMPAIGN AND CELIAC DISEASE SCREENING PROGRAM
3.1.3. INORGANIC GROWTH STRATEGIES SUCH AS MERGER & ACQUISITION
3.1.4. HIGH CONSUMPTION OF GLUTEN-CONTAINING FOOD SUCH AS BREAD, COKE, BEER AND PIZZA.
3.1.5. RISING HEALTHCARE EXPENDITURE IN DEVELOPED REGIONS
3.2.1. HIGH COST OF GLUTEN-FREE FOOD
3.2.2. GLUTEN FREE DIET BEING THE ONLY TREATMENT METHOD AVAILABLE
3.3.1. ROBUST PIPELINE FOR CELIAC DISEASE DRUGS
CHAPTER 4. MARKET SEGMENTATION
4.1. GLOBAL CELIAC DISEASE MARKET BY DIAGNOSTIC TYPE
4.1.1. SEROLOGIC TEST
4.1.2. GENETIC TESTING
4.1.3. SMALL-BOWEL BIOPSY
4.2. GLOBAL CELIAC DISEASE MARKET BY END USERS
4.2.1. HOSPITALS AND DIAGNOSTIC CENTERS
4.2.2. RESEARCH INSTITUTES
CHAPTER 5. COMPETITIVE LANDSCAPE
5.1. MARKET STRATEGY ANALYSIS
5.2. KEY COMPANY ANALYSIS
5.3. PIPELINE ANALYSIS
CHAPTER 6. REGIONAL ANALYSIS
6.1. NORTH AMERICAN
6.1.1. UNITED STATES
6.3. ASIA PACIFIC
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349